Europe midday: Selling pressure intensifies
moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]
biib
Europe open: Euro area not yet out of the crisis, Barclays says
moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]
PropThink: Biogen Idec: rFVIIIFc Trials Somewhat Disappointing, but ALS Trials Could be the Next Catalyst
[ACN Newswire] – By Ivan DeryuginThe past few months have been eventful ones for Biogen Idec (NASDAQ:BIIB), as the company awaits the FDA’s decision on BG-12 and continues to build out is pipeline. Last week, Biogen reported … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: Biogen Idec’s BG-12 PDUFA Delay is a Buying Opportunity
[ACN Newswire] – By Ivan DeryuginThe biotechnology sector can be broken up, at its simplest, into two distinct groups: the Big 4, and every other company. The Big 4 are Amgen (NASDAQ:AMGN), Celgene (NASDAQ:CELG), Gilead … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: Two Sales Forces Highlight ELN and BIIB Rift; No-Deal Is Negative For ELN
[ACN Newswire] – By David MoskowitzWe continue to believe that shares of Elan Corp. (NYSE:ELN) are trading at a premium valuation, given ongoing speculation that partner Biogen-Idec (NASDAQ:BIIB) may acquire the company … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: BG-12 Gets Extended FDA Review, ELN Likely Up Today; Look To Sell Into Strength
[ACN Newswire] – By David MoskowitzWe have written about the pressure on shares of Elan Corp. (NYSE:ELN), which has been taking place in advance of the expected market entry of Biogen Idec’s (NASDAQ:BIIB) BG-12 treatment … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: ELN Downgraded; BG-12 Raising Concerns for Tysabri Sales
[ACN Newswire] – By Jake KingElan Corp. (NYSE:ELN) is facing headwinds Monday morning after an analyst downgraded the stock based on slowing Tysabri sales growth. Leerink Swann lowered ELN’s price target from $12 to $8 … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboard […]
